Adocia SA (A89.F)
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.
3.99+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-39.6%
The outlook
Adocia SA currently reads as bearish based on below its 50- & 200-day averages, 4% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$79.8M
52-wk high
11.40
52-wk low
3.68
50-day avg
4.17
200-day avg
5.84
Trailing P/E
—